continues to exact high morbidity and mortality in patients who have a history of tobacco use. Less is known about non-tobacco related factors associated with BC-related death which may be targeted to lower the incidence or course of the disease. The mortality-to-incidence ratio (MIR) is a novel measure that has utility as a valid indicator of fatality and burden of disease. We hypothesized that a pooled county-level, population-based dataset from the United States, could demonstrate smoking and non-smoking related risk factors that may be modifiable targets in a prevention strategy.
INTRODUCTION AND OBJECTIVES: Radical cystectomy (RC) is the standard of care for invasive non-metastatic bladder cancer. Unfortunately, it is a complex procedure with more than half of patients experiencing a postoperative complication. A number of efforts to reduce perioperative morbidity have been made, including alterations in pain management, antibiotics, diet advancement, and anticoagulation. Many of these changes in management have been studied with favorable results; however, it is not clear whether complication rates following RC have improved in recent years. We sought to evaluate current temporal trends in postoperative complication rates following RC using a large national dataset.
METHODS: Using the National Surgical Quality Improvement Program (NSQIP) participant use files from 2010-2014, we identified patients who underwent RC. Demographic information as well as 30-day complications, length of stay (LOS), readmissions, and death were compared according to year of operation using univariable and multivariable analyses.
RESULTS: Over the 5-year study period, 5257 patients were identified for analysis. Age, race and comorbidity were similar across the study period. Overall, 58.0% of patients experienced a complication, which did not differ among years. A robotic approach was used in 6.1% of the entire cohort, and 16.7% of patients underwent a continent urinary diversion, both of which did not vary among years. There were no significant changes in any specific complication types over the study period. Transfusion rate varied among years with no discernible trend over the study period (range 39.9-44.9%). LOS decreased over time from 10.6 days in 2010 to 9.4 days in 2014 (p<0.01) while readmission rate increased over time from 20.1% in 2011 to 22.1% in 2014 (p<0.01). On multivariable analysis, there were no predictors of complications, readmissions, or death.
CONCLUSIONS: RC remains a procedure associated with high morbidity. While there were no improvements in complication rate, there is a slow decline in LOS, possibly at the expense of an increasing readmission rate. This is the first study to our knowledge to demonstrate an inverse relationship between trends in LOS and readmission after RC.
Source of Funding: none

MP10-03 PREOPERATIVE RISK FACTORS PREDICTING POSTOPERATIVE COMPLICATIONS IN RADICAL CYSTECTOMY FOR BLADDER CANCER
Vassili Glazyrine*, Stefan Graw, Sida Niu, Derek Jensen, Devin Koestler, Eugene Lee, Kansas City, KS
INTRODUCTION AND OBJECTIVES: INTRODUCTION:
Radical cystectomy is an extensive operation with complications reported in up to 30.5% of patients. High complication rates contribute to increased costs, patient morbidity and mortality. Accurate prospective predictions of patients' risk for post-surgical complications have the potential to identify at risk patients. Risk estimators have been developed but often involve an extensive number of factors or produce expansive results that are not clinically useful. OBJECTIVE: Clinically available preoperative risk factors were identified as potential predictors of postoperative complications, at 30 and 90 days, in patients who underwent radical cystectomy for bladder cancer. We developed a postoperative complication risk prediction model using minimal factors obtained in the normal course of preoperative history, physical and staging. not clinically useful.
METHODS: 330 patients who underwent radical cystectomy for bladder cancer from January 2008 to July 2014 were included in this e108 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Friday, May 12, 2017 study. Potential preoperative risk predictors were collected from medical history, TURBT pathology, preoperative labs, proposed procedure type, and prior treatments. Postoperative complications were graded using the Clavien-Dindo scale. Multivariate logistic regression models were used to predict post-operative complications. Accuracy of prediction models was assessed using the area under the receiver operating characteristic curve. RESULTS: Of the potential preoperative risk factors, 5, 10 and 16 unique predictors along with two way interactions were determined to have strong association with 90 day postoperative complications, yielding an AUC of 0.69, 0.79 and 0.91 respectively. This is illustrated in Figure 1 . CONCLUSIONS: Our findings suggest routinely collected preoperative patient-level clinical variables may be useful for determining patient risk for short-term postoperative complications. The flexibility in our prediction model for the number of predictor inputs allow users to tailor the degree of risk assessment based on a patient's baseline heath status. A simple and accessible prediction model with selective predictors may help identify at risk patients for patient education, counseling and development of risk reduction strategies.
Source of Funding: none
MP10-04 EFFECT OF RADICAL CYSTECTOMY AND URINARY DIVERSION FOR BLADDER CANCER TREATMENT ON RENAL FUNCTION OVER TIME
Shahab Bozorgmehri*, Gainesville, FL; Scott Gilbert, Tampa, FL; Xiaomin Lu, Robert L. Cook, Rebecca Beyth, Muna Canales, Gainesville, FL INTRODUCTION AND OBJECTIVES: We determined the effect of radical cystectomy (RC) and urinary diversion (UD) for bladder cancer treatment compared to controls on renal function over time.
METHODS: In this retrospective study of 384 patients with bladder cancer who sought care in a tertiary health care center from 2000 to 2014, we determined the effect of RC&UD (n¼172) on renal function over time using bladder cancer patients treated without RC&UD (n¼212) as a comparison group. Renal function decline was defined using (a) annualized estimated glomerular filtration rate (eGFR) decline and (b) time to decrease in eGFR of 30% or more from baseline. We used propensity score regression adjustment to address confounding by indication. Unadjusted and adjusted linear mixed-effects and Cox proportional hazards models were used to assess the association between RC&UD and eGFR slope and time to decrease in eGFR of 30% or more, respectively. RESULTS: Mean age was 68AE12 years; average follow-up was 17AE13 months. Patients with RC&UD experienced a faster decline in renal function over time as compared to those without RC&UD (see Figure) . After adjusting for age, propensity score, and other confounding variables, the difference in mean eGFR slope in patients with RC&UD, compared to those without RC&UD, was stable and remained statistically significant (p< 0.001). Patients with RC&UD had a higher risk of eGFR decline of 30% or more, compared to those without RC&UD (unadjusted HR¼1.88, 95%CI: 1.35-2.63; p<0.001); this persisted despite adjustment for age but was attenuated and no longer statistically significant after adjustment for propensity score, and confounding variables (adjusted HR¼1.01, 95% CI: 0.62-1.63; p¼0.976).
CONCLUSIONS: RC&UD was independently associated with a faster decline in renal function over time, as measured by annualized eGFR decline. RC&UD was associated with higher risk of eGFR decline of 30% or more in unadjusted analysis but not in adjusted analysis. Our findings will inform future prospective studies to examine this association and investigate intervention strategies to prevent renal injury in this population. 
Source of
MP10-05 IS DE NOVO UPPER TRACT UROTHELIAL CARCINOMA A DISTINCT ENTITY FROM BLADDER CARCINOMA?
Hanan Goldberg*, Thenappan Chandrasekar, Zachary Klaassen, Robert Hamilton, Girish Kulkarni, Neil Fleshner, Toronto, Canada INTRODUCTION AND OBJECTIVES: Upper tract urothelial carcinoma (UTUC) accounts for <5% of all urothelial cancers (UC). It is usually considered a part of the spectrum of UC, manifesting as bladder cancer (BC) primarily. Our objective was to find whether there are clinical differences between UTUC tumors that present de novo (DnU-TUC) and those that present secondarily (SUTUC)(i.e.: having had a prior history of BC).
METHODS: The SEER database was queried for all patients with UTUC from 1988-2013. Data collected consisted of demographic, clinical, pathologic and survival parameters. All parameters were compared between DnUTUC and SUTUC patients, including survival analyses.
RESULTS: A total of 20,448 patients with UTUC were identified. Patients coded as MXNX or M1 were eliminated in order to determine stratum specific differences (N¼9707). Table 1 demonstrates baseline demographic, pathologic and follow-up data. Approximately 72% of patients had DnUTUC, and almost 28% had a prior history of BC. Patients with DnUTUC were on average: younger, more likely to be female and more racially diverse. DnUTUC tumors tended to be larger, disproportionately high grade and stage. Interestingly, renal pelvic tumors were more prevalent as well. In terms of survival (Table 2) , covariates associated with diminished CSS include: increasing age, tumor size, stage and grade and whether the tumor was de novo. Furthermore, variables associated with impaired OS include: (increasing age, tumor size, stage and grade).
